Rapid advances in technology have demonstrated the capability of terahertz spectroscopy in various healthcare applications. The focus on using terahertz spectroscopy in biomedical applications has increased rapidly, and several studies are being conducted to investigate its potential applications in pharmaceutical quality control, protein characterization, and cancer detection. T-rays are non-invasive and non-ionizing and thus can be focused harmlessly on the body to capture signs of cancer. Due to these advantages, terahertz spectroscopy is used in a number of cancer-related research activities. This is key factor increasing demand of molecular spectroscopy market.
What the Industry Looks Like?
The global molecular spectroscopy market is expected to reach USD 6.85 billion by 2022 from USD 4.98 billion in 2017, at a CAGR of 6.6%.
Pharmaceutical Application:
Based on application, the molecular spectroscopy market is segmented into pharmaceutical applications, environmental testing, food and beverage testing, biotechnology and biopharmaceutical application, academic research and other applications. During the forecast period, the pharmaceutical application is expected to grow at the highest CAGR. This growth is mainly due to the growing importance of molecular spectroscopy in various stages of drug development and increasing R&D in pharmaceutical industries.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50034395
Key Factors Driving Industry Growth:
1. Applications of Molecular Spectroscopy in Environmental Screening
2. Growing Use of Molecular Spectroscopy in Pharmaceutical & Biotechnology Industries
3. Technological Advancements in Molecular Spectroscopy Systems
4. Growing Focus on Ensuring the Quality of Food Products
5. Potential Applications of Terahertz Spectroscopy in Healthcare
Key Players in Molecular Spectroscopy Market:
Bruker (US), Thermo Fisher Scientific, Inc. (U.S), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Danaher Corporation (US), ABB (Switzerland), Merck KGaA (Germany), JEOL Ltd. (Japan), FOSS (Denmark), JASCO, Inc. (US), and HORIBA Ltd. (US)
Bruker corporation, Inc. (U.S.) is one of the major player in the molecular spectroscopy market in 2016. The company provides a wide range of molecular spectroscopy technologies, accessories, and software in the market.
What are the latest trends Molecular Spectroscopy Market?
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market.The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.
Antibodies segment to dominate the global immunohistochemistry marketBased on products, the market is segmented into antibodies, reagents, kits, and equipment.
In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market.
The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.Diagnostics segment accounted for largest share of immunohistochemistry marketImmunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing.
The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases.
The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain.
According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period.
However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018.
The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips.
It would contribute to the market growth in the forthcoming years.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market.
They are as follows:uFluidixPerkin ElmerFluidigmBlacktrace Holdings Ltd. (Dolomite Microfluidic)MicronitBioFluidix GmbHFluigentALine, Inc.PhilipsThe report consists of the latest releases and new mechanical enhancements to engage the consumers to settle on instructed business decisions, design, and complete their required executions.
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R spending, technological advancements in HTS, and the availability of government funding and venture capital investments.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42710391High Content Screening Market is segmented into following types:* High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner.
High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.
* Based on product, the global market is broadly segmented into instruments, consumables, software, services, and accessories.
The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022.
Among all high content screening products, instrument segment caters to the largest share.
The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42710391Some of The Major Players In High Content Screening Market :1.
Rising extensive research for better healthcare is driving the growth of global molecular diagnostics market in the forecast period, 2022-2026.According to TechSci Research report, “Global Molecular Diagnostics Market By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”, the global molecular diagnostics market is projected to reach USD80.45 billion by 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19.Furthermore, geriatric population is more prone to get infected with chronic and target diseases like cancer, lung diseases, Parkinson’s disease, heart diseases, diabetes, and require molecular diagnostics that would drive the market growth in the upcoming five years.
Diseases like cancer, viral infections, neurological diseases including Alzheimer’s and Dementia are very risk prone for the old age patients.
All these factors together with rising COVID-19 cases are anticipated to support the growth of the global molecular diagnostic market in the next five years.
Moreover, rising cases of COVID-19 during 2020 and 2021 have raised the demand for RT-PCR testing which is likely to have a positive influence towards the growth of the market.A collection of techniques that are used to analyze the biological markers in genome and proteome, and to understand the cells expressions as proteins while applying molecular biology to medical testing.
Molecular diagnostics have widespread applications in neurological disorders, neuro degenerative diseases like Alzheimer’s, Parkinson’s, dementia, brain tumors, chronic depression, and more due to early and effective diagnosis.Browse over 138 market data Figures spread through 110 Pages and an in-depth TOC on “Global Molecular Diagnostics Market"https://www.techsciresearch.com/report/molecular-diagnostics-market/7463.htmlThe global molecular diagnostics market is segmented into products and services, technology, application, end user, regional distribution, and competitional landscape.
Procedures like extraction of the genetic material, amplification of the genetic material, and separation of the proteins and other biomolecules require reagents and kits that can aid the research of the respective procedures.
The report on the Global Cell Isolation Market provides at the close goings-on and shakeups caused by COVID-19 pandemic.
Reports that appraise the healthcare industry have been made accessible by Market Research Future, which produces reports on several industry verticals that examine the market growth and prospects.The cost-effective benefits harnessed from the use of cell isolation techniques is expected to be a major factor motivating the development of the market in the coming years.
Additionally, the region is also technologically progressive, and emerging countries in the region possess considerably established healthcare sectors which are at the forefront of pioneering research and technology.
The incidence of an enormous population with a substantial patient pool as compared to other regions and the continuing initiatives presented by the government to restructure the healthcare sector is projected to motivate the market.
Nations such as Singapore, Australia, and Malaysia, among others, are the greatest lucrative markets in the region and include large patient pools, increased amount of geriatric population and quickly improving healthcare facilities.
Though, a supportive regulatory framework concerning biotechnology research is anticipated to lift market growth.Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cell-isolation-market-6193Cell Isolation Market Competitive AnalysisThe growth of the market is influenced by the presence of factors that are stimulating the growth of the market.
http://www.lovelacebiomedical.org/services/biotechnology-lab/Lovelace has a pioneer biotechnology testing lab in the USA and we have huge experience in biotechnology to perform all your biotechnology research.
The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R spending, technological advancements in HTS, and the availability of government funding and venture capital investments.Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42710391High Content Screening Market is segmented into following types:* High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner.
High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.
* Based on product, the global market is broadly segmented into instruments, consumables, software, services, and accessories.
The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022.
Among all high content screening products, instrument segment caters to the largest share.
The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=42710391Some of The Major Players In High Content Screening Market :1.
Rising extensive research for better healthcare is driving the growth of global molecular diagnostics market in the forecast period, 2022-2026.According to TechSci Research report, “Global Molecular Diagnostics Market By Products and Services (Reagents and Kits, Instruments, Services and Software), By Technology (Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and microarrays, Mass spectrometry, Others), By Application (Infectious disease, Oncology testing, Genetic testing, Blood screening, Others), By End User (Hospitals, Academic & Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2026”, the global molecular diagnostics market is projected to reach USD80.45 billion by 2026, owing to increasing geriatric population and rising cases of infectious diseases including COVID-19.Furthermore, geriatric population is more prone to get infected with chronic and target diseases like cancer, lung diseases, Parkinson’s disease, heart diseases, diabetes, and require molecular diagnostics that would drive the market growth in the upcoming five years.
Diseases like cancer, viral infections, neurological diseases including Alzheimer’s and Dementia are very risk prone for the old age patients.
All these factors together with rising COVID-19 cases are anticipated to support the growth of the global molecular diagnostic market in the next five years.
Moreover, rising cases of COVID-19 during 2020 and 2021 have raised the demand for RT-PCR testing which is likely to have a positive influence towards the growth of the market.A collection of techniques that are used to analyze the biological markers in genome and proteome, and to understand the cells expressions as proteins while applying molecular biology to medical testing.
Molecular diagnostics have widespread applications in neurological disorders, neuro degenerative diseases like Alzheimer’s, Parkinson’s, dementia, brain tumors, chronic depression, and more due to early and effective diagnosis.Browse over 138 market data Figures spread through 110 Pages and an in-depth TOC on “Global Molecular Diagnostics Market"https://www.techsciresearch.com/report/molecular-diagnostics-market/7463.htmlThe global molecular diagnostics market is segmented into products and services, technology, application, end user, regional distribution, and competitional landscape.
Procedures like extraction of the genetic material, amplification of the genetic material, and separation of the proteins and other biomolecules require reagents and kits that can aid the research of the respective procedures.
Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years.
However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market.The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.
Antibodies segment to dominate the global immunohistochemistry marketBased on products, the market is segmented into antibodies, reagents, kits, and equipment.
In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market.
The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.Diagnostics segment accounted for largest share of immunohistochemistry marketImmunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing.
The global market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases.
The report on the Global Cell Isolation Market provides at the close goings-on and shakeups caused by COVID-19 pandemic.
Reports that appraise the healthcare industry have been made accessible by Market Research Future, which produces reports on several industry verticals that examine the market growth and prospects.The cost-effective benefits harnessed from the use of cell isolation techniques is expected to be a major factor motivating the development of the market in the coming years.
Additionally, the region is also technologically progressive, and emerging countries in the region possess considerably established healthcare sectors which are at the forefront of pioneering research and technology.
The incidence of an enormous population with a substantial patient pool as compared to other regions and the continuing initiatives presented by the government to restructure the healthcare sector is projected to motivate the market.
Nations such as Singapore, Australia, and Malaysia, among others, are the greatest lucrative markets in the region and include large patient pools, increased amount of geriatric population and quickly improving healthcare facilities.
Though, a supportive regulatory framework concerning biotechnology research is anticipated to lift market growth.Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cell-isolation-market-6193Cell Isolation Market Competitive AnalysisThe growth of the market is influenced by the presence of factors that are stimulating the growth of the market.
The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain.
According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period.
However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018.
The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips.
It would contribute to the market growth in the forthcoming years.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market.
They are as follows:uFluidixPerkin ElmerFluidigmBlacktrace Holdings Ltd. (Dolomite Microfluidic)MicronitBioFluidix GmbHFluigentALine, Inc.PhilipsThe report consists of the latest releases and new mechanical enhancements to engage the consumers to settle on instructed business decisions, design, and complete their required executions.
http://www.lovelacebiomedical.org/services/biotechnology-lab/Lovelace has a pioneer biotechnology testing lab in the USA and we have huge experience in biotechnology to perform all your biotechnology research.